Suppliers / Gland Chemicals

Gland Chemicals

India Updated 9 July 2026

Gland Chemicals is an API manufacturer based in India. It holds 6 active US drug master files across a filed portfolio of 7 molecules. Its GMP standing is certified by CDSCO (India). Customs aggregates show $160K of exports covering 25 molecules to 5 destinations in 2025.

6
active US DMFs
0
valid CEPs
3
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Kancheepuram, India Not on file
kolar, India Not on file
Malur, India Not on file

What they file, and where

Molecule Regulators Docs
Bortezomib SFDA (Saudi Arabia), US FDA 2
Pemetrexed SFDA (Saudi Arabia), US FDA 2
Dexmedetomidine SFDA (Saudi Arabia) 1
Ertapenem US FDA 1
Gemcitabine US FDA 1
Meropenem US FDA 1
Rocuronium US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) None 4

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $51K 3
2025 Not reported $160K 5
2024 Not reported $43K 3
2023 Not reported $122K 5

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Gland Chemicals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts